Product Name:Cascara Sagrada Extract
Latin Name:Rhamnus Purshiana
CAS No.:84650-55-5
Plant Part Used:Bark
Assay:Hydroxyanthracene Glycosides≧10.0%,20.0% by UV 10:1 20:1
Colour: Brown fine powder with characteristic odor and taste
GMO Status:GMO Free
Packing: in 25kgs fiber drums
Storage:Keep container unopened in cool, dry place,Keep away from strong light
Shelf Life:24 months from date of production
Cascara Sagrada Extract Hydroxyanthracene Glycosides: Product Description
1. Product Overview
Cascara Sagrada Extract is derived from the dried bark of Rhamnus purshiana (syn. Frangula purshiana), a tree native to the Pacific Northwest. Renowned for its natural laxative properties, this extract is standardized to contain 8.0–25.0% hydroxyanthracene glycosides, with ≥60% cascarosides (expressed as cascaroside A) . This formulation complies with the stringent specifications of the European Pharmacopoeia and British Pharmacopoeia, ensuring consistent potency and safety .
2. Key Active Constituents
- Hydroxyanthracene Glycosides:Other Compounds: Emodin, chrysophanic acid, and tannins, which may contribute to secondary therapeutic effects .
- Primary components include cascarosides A, B, C, D (diastereoisomeric pairs) and aloe-emodin-8-O-glucoside .
- Cascarosides constitute 60–70% of total hydroxyanthracene derivatives, responsible for stimulating colonic peristalsis to relieve constipation .
3. Therapeutic Benefits
- Natural Laxative: Effectively alleviates occasional and habitual constipation by enhancing intestinal motility .
- Colon Tonic: Restores normal bowel function without causing dependency when used short-term .
4. Quality & Production Standards
- Source: Bark aged ≥1 year to optimize bioactive content .
- Extraction: Uses boiling water or hydroalcoholic solvents (≥60% ethanol) to preserve cascarosides .
- Testing:
- TLC and UHPLC-DAD ensure precise quantification of hydroxyanthracene glycosides and cascarosides .
- Absorbance ratios (515 nm/440 nm) validated to avoid false results .
5. Safety & Regulatory Compliance
- Contraindications:
- Not for use during pregnancy, breastfeeding, or in individuals with intestinal obstructions, Crohn’s disease, or ulcers .
- Avoid prolonged use (>1–2 weeks) to prevent electrolyte imbalance .
- Label Warnings (per EU/US guidelines):
- “Do not use in children under 12 years” .
- “Discontinue if diarrhea or abdominal pain occurs” .
6. Applications
- Pharmaceuticals: Core ingredient in laxative tablets and syrups .
- Supplements: Available in powder form (2%–50% cascarosides) for capsules or functional foods .
- Cosmetics: Potential inclusion in skincare products for anti-inflammatory properties .
7. Packaging & Storage
- Form: Brown free-flowing powder .
- Shelf Life: 3 years in airtight, light-resistant packaging